At 72 weeks, adults receiving tirzepatide achieved a 20.2% weight loss vs
Compounds such as MK-0493 and MC4-NN2-0453, which do not activate MC4R as potently as other agonists, demonstrated no weight loss in humans despite dosing for 126 and 70 days, respectively (48, 49, 57)
This training made me realize that the future of healthcare isnt just about prescribing its about integrating nutrition into therapy to achieve real healing
Wang Y, Fan L, Huang J, Liang J, Wang X, Ren Y, et al
Remember, every journey with PCOS is unique, and finding the right combination of treatments often requires patience, persistence, and professional guidance